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Abstract 
The present study was undertaken to explore the possible role of serum lipid profile in gallstone 
formation. For this serum lipid profile such as total, free and bound cholesterol, LDL cholesterol, 
HDL cholesterol, triacylglycerols and total lipids were determined in 109 gallstone patients and 
100 controls (matched for age, sex and with negative personal or family history of gallstones) 
treated at Liaquat University Hpspital, Jamshoro, Pakistan. Comparison for serum lipid profile 
between different groups of gallstone patients and controls revealed no significant variation except 
for the triacylglycerols and total lipids, which were differed significantly between females of up to 
45 and above 45  years age. Comparison for serum lipid profile between pure cholesterol and 
mixed composition gallstone formers showed no significant difference (p>0.05) between the two 
groups. The serum lipid profile significantly varied between gallstone patients and controls except 
bound cholesterol level. Comparison of total cholesterol, free cholesterol, LDL cholesterol, HDL 
cholesterol, triacylglycerols and total lipids between gallstone patients and controls revealed that 
there was a significant difference between gallstone patients and controls for (a) females with or 
without gallstones, (b) females of up to 45 years age and (c) females having more than 3 children. 
HDL cholesterol is significantly decreased in all the groups of gallstone patients as compared to 
controls,  whereas,  bound  cholesterol  remained  non  significant  in  all  the  groups  of  gallstone 
patients  when  compared  with  controls.  In  conclusion,  elevated  serum  total  cholesterol,  free 
cholesterol, LDL cholesterol, triacylglycerols and decreased levels  of  HDL cholesterolseem to 
play major contributing role in the pathogenesis of gallstones in females of upto 45 years age with 
more than three children.. 
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Introduction 
 
In  Pakistan,  hypercholesterolemia  is  common 
finding  in  adults  and  pure  cholesterol  gallstones 
are more common as compared to other types of 
gallstones [1]. Cholesterol is water insoluble lipid, 
and  is  taken  in  mixed  micelles  and  vesicles. 
Micelles  are  aggregates  of  phospholipids,  bile 
salts,  and  cholesterol,  and  vesicles  are  closed 
spherical bilayers of phospholipids with associated 
cholesterol.  There  are  three  stages  of  gallstone 
formation,  supersaturation,  nucleation  and 
aggregation [2]. Cholesterol  crystals form  on the 
surfaces  of  these  vesicles  and  grow  within  the 
mucin gel. Cholesterol crystals are glued together 
by bile proteins to make gallstones [3 ￿ 6]. 
 
The relative concentrations of cholesterol, 
bile  salts  and  phospholipids  determine  the 
cholesterol  solubility  in  bile  [7].  Cholesterol 
precipitation  results  from  an  imbalance  of  these 
three components in bile; cholesterol, bile salts and 
*Corresponding Author Email: nachanna2000@gmail.com   Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
 
60 
phospholipids  [8].  These  changes  in  bile 
composition are closely related to the disorders of 
lipid  metabolism  in  liver.  However,  during  the 
formation of cholesterol gallstones, different links 
in  the  disturbance  of  lipoprotein  cholesterol 
metabolism [9] and their effects in lithogenesis still 
have  many  controversies.  Some  investigators 
reported that gallstone patients had hyperlipidemia 
[10 ￿ 12]. The paucity of information regarding the 
association  between  serum  lipid  profile  and 
gallstone  formation  tempted  us  to  undertake  the 
present study. 
 
Experimental 
 
The  materials  for  this  study  were  109 
gallstone patients (98 females and 11  males, age 
range 23.7 to 64.7 years) and 100 control inpatients 
(90 females and 10 males, age range 24 to 65) with 
no personal or family history of gallstones. All the 
gallstone samples recovered from the patients were 
analyzed  for  composition  by  Fourier  transform 
infrared  spectroscopy.  Total  serum  cholesterol 
was  estimated  by  as  per  reported  method  [13], 
whereas, the method used for the estimation of free 
cholesterol was of Parkh and Jung [14]. The bound 
cholesterol  was  calculated  from  the  difference 
between the total cholesterol and free cholesterol 
[15  ￿  16].  High  density  lipoprotein  cholesterol 
(HDL-C) and Low density lipoprotein cholesterol 
(LDL-C)  were  estimated by CHOD-PAP  method 
[15 ￿ 17].  Triacylglycerol  level  was  determined 
according to Rifai  et al. and Cole et al. [17 ￿ 18]. 
Total lipids were determined by Zollner and Kirch 
method [19]. All the chemicals and reagents used 
were  of  analytical  reagent  grade,  supplied  by  E. 
Merck,  W.  Germany.  Microlab  200,  Merck  was 
used  for  the  analysis  of  serum  total  cholesterol, 
whereas  double  beam  UV-visible 
spectrophotometer,  L-2800  Hitachi  was  used  for 
free  cholesterol analysis. All the results for  each 
sample  were  in  triplicates  for  each  parameter  of 
lipid profile; the mean for each sample was used in 
statistical analysis.  
 
Statistical analysis 
 
Results were expressed as mean – SD and 
mean – SEM. Student￿s t test was used to compare 
the data between patients and control groups and 
between  the  patients  distributed  in  different 
groups,  (p<0.05  was  considered  statistically 
significant).  Minitab  software,  version  13.2  was 
used for statistical analysis. 
 
Results and Discussion 
 
Comparison of serum lipid profile between 
different groups of gallstone patients and controls 
showed  no  significant  variation  except  for  the 
triacylglycerols  and  total  lipids,  which  were 
significantly  raised  in  females  of  up  to  45  years 
age  than  the  females  above  45  years  (Table  1). 
Comparison for serum lipid profile between pure 
cholesterol  and  mixed  composition  gallstone 
formers (Table 2) showed no significant difference 
(p>0.05) between the two groups. The serum lipid 
profile  significantly  differed  (p<0.05)  varied 
between gallstone patients and controls except for 
bound cholesterol level (Fig. 1). 
 
Interestingly, the association seen between 
serum cholesterol levels and mixed composition 
gallstones in the present study was of the same 
pattern  as  that  with  cholesterol  gallstones     
(Table 2).  This suggests that serum lipids do play 
just  as  big  a  role  in  the  pathogenesis  of  mixed 
composition  gallstones  as  in  that  of  pure 
cholesterol  gallstones.  As  a  corollary,  mixed 
composition and cholesterol gallstones may share 
more  causal  determinants  than  previously 
suggested. This is supported by the finding of a 
similar  serum  cholesterol  pattern  in  mixed  and 
cholesterol  gallstone  formers  and  is  consistent 
with  the  hypothesis  that  the  association  of 
gallstones  with  serum  cholesterol  is  merely  a 
consequence  of  an  influence  of  the  presence  of 
gallstones  on  serum  cholesterol  levels.  Because 
the  present  study  cannot  distinguish  between 
cause  and  effect  and  also  because  of  the      
limited  power  of  this  study  to  detect  subtle 
differences  between  mixed  and  cholesterol 
gallstones with respect to serum lipids, the results 
of  the  present  study  need  to  be  confirmed  by 
further studies. 
 
Figures  2,  3,  6,  7  and  8  showed  the 
comparison  of  total  cholesterol,  free  cholesterol, 
LDL cholesterol, triacylglycerols, and total lipids 
between gallstone patients and controls. A closer 
look at those figures revealed that these parameters 
in comparison   to   corresponding   controls    were Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
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Table 1. Comparison of serum lipid levels between different groups of gallstone patients. 
 
Groups  Total 
 
Cholesterol 
(≤    
mg/dl) 
Mean   
SEM 
Free  
Cholesterol 
(5-40 
mg/dl) 
Mean   
SEM 
Bound  
Cholesterol 
(195-60 
mg/dl) 
Mean     
HDL- 
Cholesterol 
(35-55mg/ 
dl males) 
(45-65mg/dl  
females) 
Mean     
LDL-  
Choles-terol 
 (≤      
/dl) 
Mean     
Triacylglycerols 
(<150mg/dl) 
Mean    EM 
Total lipids 
(450 ￿ 1000 
mg/dl) 
Mean   
SEM 
Females (N=98)  199.3 – 5.4  44.8 – 2.5  154.1 – 4.0  23.9 – 0.28  118.7 – 3.8  191.4 – 10.0  948.0 – 34.0 
Males (N=11)  183.4 – 13  40.3 – 6.4  143.1 – 9.9  21.3 – 1.2  108.3 – 9.2  173.0 – 21.0  899.0 – 53.0 
p value   0.275  0.525  0.324  0.085  0.315  0.437  0.441 
Females of upto 45 years age 
group (N=71) 
 
204.4 – 6.8  47.1 – 3.2  156.9 – 4.9  23.77 – 0.9  121.4 – 4.7  202.0 – 13.0  993.0 – 41.0 
Females of above 45 years age 
group (N=27) 
 
185.7 – 7.9  38.7 – 3.3  146.6 – 6.7  24.2 – 1.6  111.6 – 6.1  162.6 – 14.0  828.0 – 50.0 
p value   0.077  0.075  0.222  0.811  0.208  0.036*  0.013* 
Females having up to 3 children  
(N = 81) 
 
198.6 – 5.7  44.5 – 2.8  153.6 – 4.2  24.09 – 0.9  117.8 – 4.1  195.2 – 11.0  971.0 – 39.0 
Females having more than 3 
children (N = 17) 
 
202.3 – 16.0  46.1 – 5.7  156.2 – 12.0  22.9 – 1.4  122.8 – 11.0  173.0 – 25  838.0 – 59.0 
p value   0.827  0.808  0.837  0.472  0.669  0.428  0.060 
 
* p<0.05 (level of significance) 
 
 
Table 2. Comparison of serum lipid levels between pure cholesterol and mixed composition gallstone formers. 
 
Serum Cholesterol levels 
(mg/dl) 
Pure Cholesterol stone formers 
(n=74) 
Mean       
Mixed composition stone 
formers (n=23) 
Mean       
P (<0.05) 
Total Cholesterol 
(≤200mg/dl) 
 
195.8 – 14.0 
 
 
195.2 – 8.5 
 
 
0.97 
 
 
Free Cholesterol 
(5-40mg/dl) 
 
39.34 – 5.3 
 
42.3 – 4.7 
 
0.68 
 
Bound Cholesterol 
(195-160mg/dl) 
 
156.45 – 9.5 
 
152.3 – 6.1 
 
0.72 
 
HDL-Cholesterol 
(35-55mg/dl males) 
(45-65mg/dl females) 
 
22.35 – 1.4 
 
 
23.79 – 1.5 
 
 
0.48 
 
 
LDL-Cholesterol 
(≤150mg/dl) 
 
121.23 – 9.9 
 
118.7 – 5.8 
 
0.82 
 
Triacylglycerols 
(<150mg/dl) 
 
220.91 – 25.0 
 
194.9 – 18.0 
 
0.40 
 
Total Lipids 
(450 -1000mg/dl) 
1060 – 95.0  1014 – 72.0  0.69 
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Figure  1.  Comparison  of  serum  lipid  profile  between  gallstone 
patients and control subjects. * p<0.05. Each value is mean       
 
 
 
Figure 2.  Comparison  of  serum  total  cholesterol  between 
different  groups  of  patients  and  controls.  *p<.05.  Each  value  is 
mean        
 
 
Figure 3. Comparison of serum free cholesterol between different 
groups  of  patients  and  controls.  *p<.05.  Each  value  is  mean    
SEM. 
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Figure  4.  Comparison  of  serum  bound  cholesterol  between 
different groups of patients and controls. Each value is  mean   
SEM. 
 
Figure  5.  Comparison  of  serum  HDL-  cholesterol  between 
different groups of patients and controls. * p<.05. Each value is 
mean        
 
 
Figure  6.  Comparison  of  serum  LDL-  cholesterol  between 
different groups of patients   and controls. * p<.05. Each value is 
mean       
 
 
 
Figure 7. Comparison of serum Triacylglycerols between different 
groups of patients   and controls. * p<.05. Each value is mean   
SEM. 
 
 
Figure  8.  Comparison  of  serum  total  lipids  between  different 
groups of patients  and controls. * p<.05. Each value is  mean   
SEM. Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
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significantly  raised  in:  (a)  female  gallstone 
patients, (b) female gallstone patients of up to 45 
years age and (c) female gallstone patients having 
more than three children. 
 
Significantly  high  concentrations  of  total 
cholesterol in serum found in females of up to 45 
years age and having more than three children in 
present  study  (Fig.  2)  seem  to  be  in  accordance 
with  the  findings  of  other  investigators  who  had 
reported a positive association of total cholesterol 
with  gallstone  disease  in  females  [20  ￿  22]. 
Interestingly,  this  positive  association  between 
total cholesterol and gallstones or gallstone disease 
(including cholecystectomy) had been seen not only 
in females but also in males [12, 23, and 24]. The 
present finding that females of up to 45 years age 
have  high  levels  of  serum  total,  free  and  bound 
cholesterol  (Fig. 2, 3 and 4) seems to be in line 
with the reports of other investigators who found 
that positive association between serum cholesterol 
levels  and  gallstone  disease  is  confined  to 
multiparous female patients less than 50 years age 
[24].  One  of  the  case-control  studies  reported 
lower concentrations for total cholesterol in gall-
stone  patients  than  in  control  subjects  in  both 
genders  separately  [24]  or  collectively  [25]. 
Population studies based on gallbladder screening 
had  reported  a  positive  relation  [26],  an  inverse 
relation [27], or no relation [28, 29] between total 
cholesterol and gallstone disease in both genders 
combined.  Some  similar  studies  had  found  an 
inverse  association  with  prevalent  gallstones  in 
females [23] but not in males [23, 30]. This may 
be  due  to  random  selection  of  patients  due  to 
which more female patients of up to 45 years age 
can  be  recruited  (in  which  the  serum  LDL 
cholesterol  is  significantly  high)  or  it  may  be 
because of genetics [31 ￿ 38] as well as age and 
gender  [39  ￿  40]  difference,  since  all  these 
variables affect on serum lipid profile of patients. 
  
In present study serum bound cholesterol 
remained  non  significant  the  groups  of  gallstone 
patients  when  compared  to  controls  (Fig.  4). 
Kritchevsky had reported that the free and bound 
cholesterol  fractions  have  distinct  and  separate 
metabolic  functions.  Free  cholesterol  may  be 
esterified to form bound cholesterol, in  doing so 
the specific  metabolic function  may change. The 
major function of free cholesterol is to serve as a 
substrate for steroid synthesis and for the renewal 
of blood cells and tissues and the bound cholesterol 
as part of the fatty acid transport mechanism [41]. 
Hence, in present study free cholesterol increases 
steroid  synthesis,  this  in  turn  decreases  the 
production  of  bile  acids  and  hence  of  bile  salts 
which  keep  the  cholesterol  soluble  in  bile. 
Decreased concentration of bile salts is responsible 
for the precipitation of cholesterol in bile, which is 
prerequisite for gallstone formation [2].  
 
Some  investigators  reported  a  positive 
association  between  gallstone  and  serum 
triacylglycerol levels (in Spanish men [42]) [43], 
whereas, others found no such association [44, 
45].  Present  study  has  shown  significant 
variations  in  triacylglycerol  levels  though  in 
normal range (<150mg/dl) in the same groups as 
in case of total cholesterol (Figs. 2 and 7). This 
suggests  a  positive  association  between 
gallstone  disease  and  serum  cholesterol  and 
triacylglycerol levels. 
 
HDL cholesterol is significantly decreased 
in all the groups of gallstone patients as compared 
to  controls  (Fig.  3).  Previous  investigators  had 
reported  that  high  serum  cholesterol  levels  are 
caused by the presence of an abnormal LDL class 
(LP-X)  [46  ￿  48]  in  patients  of  intrahepatic  or 
extrahepatic cholestasis and low HDL levels with 
an abnormal HDL component [49]. This suggests 
that changes in serum lipid profile are a possible 
consequence  of  the  presence  of  gallstones, 
especially through biliary obstruction. In present 
study,  because  only  few  gallstone  patients  had 
experienced  symptoms  of  biliary  obstruction  in 
the past (jaundice, pale stools, or dark urine), it is 
believed that only few of them would have had 
cholestasis at the time of the study. Nevertheless, 
more  subtle  changes  in  lipid  profile  as  a 
consequence  of  the  presence  of  gallstones 
cannot  be  excluded.  In  this  respect,  it  had  been 
reported that serum lipid profile in subjects with a 
history  of cholecystectomy  was more similar to 
controls than to gallstone patients [23]. 
 
Some  investigators  found  a  positive 
association  between  gallstone  disease  and 
increased  levels  of  serum  triacylglycerols,  LDL 
cholesterol  and  decreased  HDL  cholesterol        
[50,  51].  Present  study  also  suggests  the  same Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
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associations as indicated by above investigators. A 
brief  review  of  previous  studies  had  not  clearly 
indicated  any  existence  of  the  relation  between 
serum  lipid  profile  and  gallstone  disease.  Serum 
lipid  profile  in  present  study,  however,  is 
comparable with the findings of other investigators 
from Europe.  
 
Conclusion 
 
In  conclusion,  elevated  serum  total 
cholesterol,  free  cholesterol,  LDL  cholesterol, 
triacylglycerols  and  decreased  levels  of  HDL 
cholesterolseem to play major contributing role in 
the pathogenesis of gallstones in females of upto 
45 years age with more than three children. 
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